10 years ago today I started at The Economist Group. My journey has taken me from Europe Editor at the height of the euro zone debt crisis to covering major global health challenges to leading projects on some of the most exciting sustainability issues of our time.
This new index is a useful benchmarking tool to help policymakers and other key stakeholders to identify where their countries stand in cancer control compared with their peers and how they can boost their preparedness.
An article I edited looks at healthy ageing. Those interviewed for the article say that the key aim of governments and policymakers should be looking at ways to improve the quality of life of older people and help them to stay well and independent for longer.
On February 16th 2018 I gave a keynote address for the session “Emerging global trends in self-care and relevance of OTC regulatory framework for Indian public healthcare system” as part of the India Pharma & India Medical Device 2018 conference organised by the Federation of Indian Chambers of Commerce & Industry. The presentation was part...
In this report that I edited, we look at the current national and EU-level approaches to obesity policy, identify the weaknesses in current efforts, and discuss how strategies might be adapted to confront the scale of the obesity problem more effectively.
A combination of major lifestyle and dietary changes over the past few decades, harsh weather conditions that limit outdoor activities and a genetic predisposition has led to an obesity crisis in many parts of the Middle East. A report on this topic that I edited has just been published.
Value-based healthcare looks at health outcomes of treatment relative to cost. In a series of reports that I edited we examined the way in which value is interpreted across Europe, the extent to which European countries are adopting cost-effectiveness as a key criterion for assessing it, and the efforts to develop new pricing models.
A report that I edited assesses the current status and potential impact of diabetes in the six Gulf Co-operation Council states—Bahrain, Kuwait, Oman, Qatar, Saudi Arabia and the UAE; reviews current approaches to tackling the disease in the region; and explores further possible opportunities to help combat diabetes.